Clinical Trial

HEALEY ALS Platform Trial - Master Protocol

Name: HEALEY ALS Platform Trial - Master Protocol — clinical trial record (NCT04297683)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Active, Not Recruiting Phase 2/3

View on ClinicalTrials.gov →

Summary

The HEALEY ALS Platform Trial is a perpetual multi-center, multi-regimen clinical trial evaluating the safety and efficacy of investigational products for the treatment of ALS.

Protocol Amendment History 2 changes

critical Trial status changed: Recruiting → Active, Not Recruiting 2026-07-22

notable Trial sites expanded: 78 -> 81 locations 2026-06-05

Trial Details

NCT Number	NCT04297683
Lead Sponsor	Merit E. Cudkowicz, MD Collaborators: Massachusetts General Hospital
Conditions	Amyotrophic Lateral Sclerosis
Enrollment	1,500 participants
Start Date	2020-06-14
Primary Completion	2027-07 (estimated)
Study Completion	2028-08 (estimated)
Updated on ClinicalTrials.gov	2026-07-21